These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 9607419

  • 21. Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir.
    Smitt PS, Driesse M, Wolbers J, Kros M, Avezaat C.
    Mol Ther; 2003 Jun; 7(6):851-8. PubMed ID: 12788659
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.
    Kucharczuk JC, Raper S, Elshami AA, Amin KM, Sterman DH, Wheeldon EB, Wilson JM, Litzky LA, Kaiser LR, Albelda SM.
    Hum Gene Ther; 1996 Dec 01; 7(18):2225-33. PubMed ID: 8953313
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
    Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH.
    J Neurosurg; 1993 Sep 01; 79(3):400-7. PubMed ID: 8395592
    [Abstract] [Full Text] [Related]

  • 29. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.
    van der Eb MM, Cramer SJ, Vergouwe Y, Schagen FH, van Krieken JH, van der Eb AJ, Borel Rinkes IH, van de Velde CJ, Hoeben RC.
    Gene Ther; 1998 Apr 01; 5(4):451-8. PubMed ID: 9614568
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
    Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, Litzky L, Kaiser LR, Albelda SM.
    Gene Ther; 2001 Jun 01; 8(12):946-53. PubMed ID: 11426335
    [Abstract] [Full Text] [Related]

  • 33. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
    Packer RJ, Raffel C, Villablanca JG, Tonn JC, Burdach SE, Burger K, LaFond D, McComb JG, Cogen PH, Vezina G, Kapcala LP.
    J Neurosurg; 2000 Feb 01; 92(2):249-54. PubMed ID: 10659011
    [Abstract] [Full Text] [Related]

  • 34. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice.
    Timme TL, Hall SJ, Barrios R, Woo SL, Aguilar-Cordova E, Thompson TC.
    Cancer Gene Ther; 1998 Feb 01; 5(2):74-82. PubMed ID: 9570298
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Suicide gene therapy using adenovirus vector for human oral squamous carcinoma cell line in vitro.
    Yamamoto N, Hayashi Y, Kagami H, Fukui T, Fukuhara H, Tohnai I, Ueda M, Mizuno M, Yoshida J.
    Nagoya J Med Sci; 2005 Jun 01; 67(3-4):83-91. PubMed ID: 17375474
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.